Clinical Trial Update: Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder [Phase 2]

View source ↗

Summary

A Phase 2 double-blind, placebo-controlled trial in adults with major depressive disorder is currently recruiting, sponsored by Supernus Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Not disclosed

Snippet

Sponsor: Supernus Pharmaceuticals, Inc. | Conditions: Major Depressive Disorder (MDD) | Phase 2 | Status: RECRUITING